26.67 USD
+0.01 (+0.04%)
26.1571 USD
-0.51 (-1.92%)
Overall PGNY gets a fundamental rating of 7 out of 10. We evaluated PGNY against 101 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making PGNY a very profitable company, without any liquidiy or solvency issues. PGNY is growing strongly while it is still valued neutral. This is a good combination! These ratings would make PGNY suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year PGNY was profitable.
PGNY had a positive operating cash flow in the past year.
In the past 5 years PGNY has always been profitable.
Each year in the past 5 years PGNY had a positive operating cash flow.
1.2 Ratios
PGNY's Return On Assets of 7.11% is amongst the best of the industry. PGNY outperforms 89.11% of its industry peers.
The Return On Equity of PGNY (10.10%) is better than 72.28% of its industry peers.
PGNY has a Return On Invested Capital of 11.24%. This is amongst the best in the industry. PGNY outperforms 83.17% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PGNY is in line with the industry average of 9.21%.
The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(11.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
With a decent Profit Margin value of 4.46%, PGNY is doing good in the industry, outperforming 78.22% of the companies in the same industry.
PGNY's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 6.77%, PGNY is doing good in the industry, outperforming 70.30% of the companies in the same industry.
PGNY's Operating Margin has improved in the last couple of years.
PGNY has a Gross Margin (22.94%) which is in line with its industry peers.
In the last couple of years the Gross Margin of PGNY has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PGNY is still creating some value.
The number of shares outstanding for PGNY has been reduced compared to 1 year ago.
Compared to 5 years ago, PGNY has more shares outstanding
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 8.77 indicates that PGNY is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.77, PGNY belongs to the best of the industry, outperforming 94.06% of the companies in the same industry.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.77 |
ROIC/WACC1.25
WACC8.96%
2.3 Liquidity
A Current Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
The Current ratio of PGNY (2.96) is better than 84.16% of its industry peers.
PGNY has a Quick Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.96, PGNY belongs to the best of the industry, outperforming 84.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.62% over the past year.
The Earnings Per Share has been decreasing by -4.77% on average over the past years.
Looking at the last year, PGNY shows a quite strong growth in Revenue. The Revenue has grown by 11.41% in the last year.
PGNY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.42% yearly.
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
3.2 Future
PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.94% yearly.
PGNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.83% yearly.
EPS Next Y17.75%
EPS Next 2Y38.5%
EPS Next 3Y32.43%
EPS Next 5Y32.94%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 42.33, PGNY can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as PGNY.
The average S&P500 Price/Earnings ratio is at 27.17. PGNY is valued rather expensively when compared to this.
PGNY is valuated rather expensively with a Price/Forward Earnings ratio of 24.39.
PGNY's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.79. PGNY is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.33 | ||
| Fwd PE | 24.39 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as PGNY.
Based on the Price/Free Cash Flow ratio, PGNY is valued cheaply inside the industry as 82.18% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.88 | ||
| EV/EBITDA | 19.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PGNY does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of PGNY may justify a higher PE ratio.
PGNY's earnings are expected to grow with 32.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.39
PEG (5Y)N/A
EPS Next 2Y38.5%
EPS Next 3Y32.43%
5. Dividend
5.1 Amount
No dividends for PGNY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
26.67
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.67%
Inst Owner Change0%
Ins Owners1.48%
Ins Owner Change0.9%
Market Cap2.30B
Revenue(TTM)1.27B
Net Income(TTM)56.57M
Analysts81.25
Price Target29.68 (11.29%)
Short Float %7.13%
Short Ratio3.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.43%
Min EPS beat(2)14.22%
Max EPS beat(2)14.63%
EPS beat(4)3
Avg EPS beat(4)8.02%
Min EPS beat(4)-11.77%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)7.07%
EPS beat(12)9
Avg EPS beat(12)35.08%
EPS beat(16)13
Avg EPS beat(16)94.29%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.96%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.96%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.43%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-0.09%
PT rev (1m)1.12%
PT rev (3m)1.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.45%
EPS NY rev (1m)-14.88%
EPS NY rev (3m)6.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.33 | ||
| Fwd PE | 24.39 | ||
| P/S | 1.81 | ||
| P/FCF | 11.88 | ||
| P/OCF | 11.05 | ||
| P/B | 4.11 | ||
| P/tB | 4.31 | ||
| EV/EBITDA | 19.29 |
EPS(TTM)0.63
EY2.36%
EPS(NY)1.09
Fwd EY4.1%
FCF(TTM)2.24
FCFY8.41%
OCF(TTM)2.41
OCFY9.05%
SpS14.72
BVpS6.5
TBVpS6.19
PEG (NY)2.39
PEG (5Y)N/A
Graham Number9.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 8.77 |
F-Score7
WACC8.96%
ROIC/WACC1.25
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y17.75%
EPS Next 2Y38.5%
EPS Next 3Y32.43%
EPS Next 5Y32.94%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.6%
Revenue Next 5Y8.83%
EBIT growth 1Y31.12%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year39.66%
EBIT Next 3Y20.34%
EBIT Next 5Y15.66%
FCF growth 1Y-2.78%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y2.69%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
Can you provide the valuation status for PROGYNY INC?
ChartMill assigns a valuation rating of 4 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What is the earnings growth outlook for PROGYNY INC?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 17.75% in the next year.